0001104659-24-010797.txt : 20240205
0001104659-24-010797.hdr.sgml : 20240205
20240205185336
ACCESSION NUMBER: 0001104659-24-010797
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meeker David P
CENTRAL INDEX KEY: 0001385155
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 24597447
MAIL ADDRESS:
STREET 1: C/O PENWEST PHARMACEUTICALS CO
STREET 2: 39 OLD RIDGEBURY ROAD SUITE 11
CITY: DANBURY
STATE: CT
ZIP: 06810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
tm245251-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-01
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001385155
Meeker David P
C/O RHYTHM PHARMACEUTICALS, INC.
222 BERKELEY STREET, 12TH FLOOR
BOSTON
MA
02116
1
1
0
0
President and CEO
0
Common Stock
2024-02-01
4
M
0
14125
A
125460
D
Common Stock
2024-02-01
4
S
0
4361
45.06
D
121099
D
Restricted Stock Units
2024-02-01
4
M
0
14125
0
D
Common Stock
14125
42375
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
The restricted stock units vest or have vested as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date.
/s/ Hunter Smith, Attorney-in-Fact for David Meeker
2024-02-05